12 Health Care Stocks Moving In Friday's After-Market Session
This article lists 12 healthcare stocks that experienced significant movement in Friday's after-market trading session. Gainers include Virax Biolabs Group (VRAX), IDEAYA Biosciences (IDYA), Allogene Therapeutics (ALLO), Oncolytics Biotech (ONCY), PureTech Health (PRTC), and PharmaCyte Biotech (PMCB). Losers include Wellgistics Health (WGRX), Nasus Pharma (NSRX), Vivos Therapeutics (VVOS), Estrella Immunopharma (ESLA), Geovax Labs (GOVX), and Profusa (PFSA), with specific percentage changes and market caps provided for each.
How this was made
The 30-second read
Why it matters
Limited immediate trading impact due to modest movement and low relevance scores. The overall sector remains stable with minor fluctuations.
Market read
The reported movements are sector-specific with limited broader market influence, primarily affecting biotech and healthcare stocks.
What to watch
Potential upcoming news catalysts or sector-wide developments could alter the impact; current analysis does not account for such events.
Background
The article reports on after-market movements in healthcare stocks, highlighting specific gainers and losers with percentage changes and market caps.
Ticker impact
Moderate relevance due to positive sentiment score of 0.02958 and industry association with biotech and healthcare sectors.
Potential for minor upward movement (~1-2%) in short-term trading, contingent on broader market conditions.
The sentiment score is close to neutral, and the relevance score is moderate, suggesting limited but positive influence. No significant technical signals or volume spikes are indicated.
Low relevance due to lack of sentiment data in the provided JSON; therefore, impact is considered minimal.
No clear prediction; potential for volatility if news emerges.
Limited sentiment and relevance data reduce confidence in impact assessment.
Low relevance; no sentiment data provided, and the stock is not highlighted in the summary.
No significant movement anticipated.
Lack of sentiment data and low relevance score.
Low relevance; not included in sentiment analysis and not highlighted as a mover.
No significant change predicted.
Absence of sentiment and relevance data.
Market effects
The healthcare sector may experience slight positive bias due to biotech gains, but overall impact remains limited.
No significant regional effects expected.
Minimal global influence from these specific movers.
Counterpoint
The positive sentiment is minimal and may not sustain; some stocks could decline if broader market conditions worsen.
Key entities
- CompanyVirax Biolabs Group
Biotech company involved in healthcare products.
- CompanyIDEAYA Biosciences
Biotech firm focusing on cancer therapies.
- CompanyAllogene Therapeutics
Biotech company developing cell therapies.
- CompanyOncolytics Biotech
Biotech firm specializing in cancer treatments.
- CompanyPureTech Health
Biotech and health sciences company.
